| Product NDC: | 55648-633 |
| Proprietary Name: | Octreotide acetate |
| Non Proprietary Name: | Octreotide acetate |
| Active Ingredient(s): | 100 ug/mL & nbsp; Octreotide acetate |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55648-633 |
| Labeler Name: | Wockhardt Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090985 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110511 |
| Package NDC: | 55648-633-02 |
| Package Description: | 10 VIAL in 1 CARTON (55648-633-02) > 1 mL in 1 VIAL |
| NDC Code | 55648-633-02 |
| Proprietary Name | Octreotide acetate |
| Package Description | 10 VIAL in 1 CARTON (55648-633-02) > 1 mL in 1 VIAL |
| Product NDC | 55648-633 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Octreotide acetate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20110511 |
| Marketing Category Name | ANDA |
| Labeler Name | Wockhardt Limited |
| Substance Name | OCTREOTIDE ACETATE |
| Strength Number | 100 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |